Used primarily in pharmaceutical research, this compound serves as a key intermediate in the synthesis of various bioactive molecules. Its trifluoromethyl group enhances the metabolic stability and binding affinity of drug candidates, making it valuable in the development of therapeutic agents. It is particularly relevant in the creation of compounds targeting neurological disorders and cancer. Additionally, its unique structure allows for the exploration of novel chemical pathways in medicinal chemistry.